Alahist PE
NDC 50991-788, Dexbrompheniramine Maleate, Phenylephrine Hydrochloride, tablet, from Poly Pharmaceuticals, Inc..
- Product NDC
- 50991-788
- Status
- Listed
- Labeler
- Poly Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50991-788 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXBROMPHENIRAMINE MALEATE2 mg/1
- PHENYLEPHRINE HYDROCHLORIDE7.5 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50991-788-02 | 50991078802 | 12 TABLET in 1 BLISTER PACK (50991-788-02) |
| 50991-788-90 | 50991078890 | 90 TABLET in 1 BOTTLE (50991-788-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 50991078890
GET /v1/drugs/nadac/50991078890
Use it
Look up 50991-788 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50991-788 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50991-788. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.